YKL-40 is highly expressed in the epicardial adipose tissue of patients with atrial fibrillation and associated with atrial fibrosis

Obesity and atrial fibrillation

(2016) Gökhan Ergün et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The role of obesity in atrial fibrillation

(2015) Chrishan Joseph Nalliah et al.   EUROPEAN HEART JOURNAL

Atrial remodeling, fibrosis, and atrial fibrillation

(2015) José Jalife et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Epicardial adipose tissue and atrial fibrillation

(2014) S. N. Hatem et al.   CARDIOVASCULAR RESEARCH

Atrial Remodeling and Atrial Fibrillation

(2014) Stanley Nattel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Chitinase 3-Like 1 Suppresses Injury and Promotes Fibroproliferative Responses in Mammalian Lung Fibrosis

(2014) Y. Zhou et al.   Science Translational Medicine

Worldwide Epidemiology of Atrial Fibrillation

(2013) Sumeet S. Chugh et al.   CIRCULATION

Epicardial Adipose Tissue Thickness and Ablation Outcome of Atrial Fibrillation

(2013) Tze-Fan Chao et al.   PLoS One

YKL-40 levels and atrial fibrillation in the general population

(2012) Sarah C.W. Marott et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Atrial fibrillation

(2011) Gregory YH Lip et al.   LANCET

Increased Circulating and Visceral Adipose Tissue Expression Levels of YKL-40 in Obesity-Associated Type 2 Diabetes Are Related to Inflammation: Impact of Conventional Weight Loss and Gastric Bypass

(2010) Victoria Catalán et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pericardial Fat Is Independently Associated With Human Atrial Fibrillation

(2010) M. Obadah Al Chekakie et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Macrophages: Master Regulators of Inflammation and Fibrosis

(2010) Thomas Wynn et al.   SEMINARS IN LIVER DISEASE

YKL-40 secreted from adipose tissue inhibits degradation of type I collagen

(2009) Takeo Iwata et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes

(2009) Camilla N Rathcke et al.   Cardiovascular Diabetology

Plasma YKL-40, a new biomarker for atrial fibrillation?

(2009) K. M. Henningsen et al.   EUROPACE

High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease

(2009) J. Kastrup et al.   EUROPEAN HEART JOURNAL

YKL-40 is Elevated in Morbidly Obese Patients and Declines After Weight Loss

(2009) Moritz Hempen et al.   OBESITY SURGERY

A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection

(2008) Marie-Luise Berres et al.   JOURNAL OF HEPATOLOGY

Atrial Fibrosis: Mechanisms and Clinical Relevance in Atrial Fibrillation

(2008) Brett Burstein et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of Variation inCHI3L1on Serum YKL-40 Level, Risk of Asthma, and Lung Function

(2008) Carole Ober et al.   NEW ENGLAND JOURNAL OF MEDICINE